Anti-βs-Ribozyme Reduces βs mRNA Levels in Transgenic Mice: Potential Application to the Gene Therapy of Sickle Cell Anemia
- 30 April 1999
- journal article
- research article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 25 (2) , 110-119
- https://doi.org/10.1006/bcmd.1999.0235
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Structure, Function and Application of the Hammerhead RibozymeEuropean Journal of Biochemistry, 1997
- Sickle cell anemia is a multigene disease: Sickle painful crises, a case in pointAmerican Journal of Hematology, 1993
- High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.Proceedings of the National Academy of Sciences, 1992
- High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.Proceedings of the National Academy of Sciences, 1992
- Sickle Cell Hemoglobin PolymerizationAdvances in Protein Chemistry, 1990
- Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin geneBlood, 1986
- Kinetics of sickle hemoglobin polymerizationJournal of Molecular Biology, 1985
- Alpha-thalassemia is related to prolonged survival in sickle cell anemiaBlood, 1983
- Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S.Proceedings of the National Academy of Sciences, 1979
- Mouse Hemoglobin from Bone Marrow, Spleen, and Peripheral Blood CellsExperimental Biology and Medicine, 1970